Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Brock

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|September 16, 2017
The human microbiome: opportunity or hype?Pedro M Valencia, Magali Richard, Jesse Brock, et al.
Nature Reviews. Drug Discovery|February 3, 2017
The immuno-oncology race: myths and emerging realitiesStephen Cavnar, Pedro Valencia, Jesse Brock, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapyBoudewijn L M de Jonge, Grant K Walkup, Sushmita D Lahiri, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|September 16, 2017
The human microbiome: opportunity or hype?Pedro M Valencia, Magali Richard, Jesse Brock, et al.
Nature Reviews. Drug Discovery|February 3, 2017
The immuno-oncology race: myths and emerging realitiesStephen Cavnar, Pedro Valencia, Jesse Brock, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapyBoudewijn L M de Jonge, Grant K Walkup, Sushmita D Lahiri, et al.
Pageof 1